Effects of Dapagliflozin According to the Heart Failure Collaboratory Medical Therapy Score: Insights From DAPA-HF

Butt, J. H., Dewan, P., DeFilippis, E. M., Biering-Sørensen, T., Docherty, K. F., Jhund, P. S., Kosiborod, M. N., Martinez, F. A., Bengtsson, O., Johansen, N. D., Langkilde, A. M., Sjöstrand, M., Vaduganathan, M., Solomon, S. D., Sabatine, M. S., Køber, L., Fiuzat, M., & McMurray, J. J. V. (2022). Effects of Dapagliflozin According to the Heart Failure Collaboratory Medical Therapy Score. JACC: Heart Failure, 10(8), 543–555. https://doi.org/10.1016/j.jchf.2022.03.009
Authors:
Jawad H. Butt
Pooja Dewan
Ersilia M. DeFilippis
Tor Biering-Sørensen
Kieran F. Docherty
Pardeep S. Jhund
Mikhail N. Kosiborod
Felipe A. Martinez
Olof Bengtsson
Niklas Dyrby Johansen
Anna Maria Langkilde
Mikaela Sjöstrand
Muthiah Vaduganathan
Scott D. Solomon
Marc S. Sabatine
Lars Køber
Mona Fiuzat
John J.V. McMurray
Affiliated Authors:
Ersilia M. DeFilippis
Columbia Affiliation:
Subjects:
Management of Diabetes Mellitus and Cardiovascular Risk (OpenAlex Topic)
Diagnosis and Treatment of Heart Failure (OpenAlex Topic)
Recommendations for Cardiac Chamber Quantification by Echocardiography (OpenAlex Topic)
Diabetes Mellitus, Type 2 (MeSH)
Heart Failure (MeSH)
Ventricular Dysfunction, Left (MeSH)
Author Keywords:
clinical trial
dapagliflozin
heart failure
heart failure collaboratory (hfc)
heart failure collaboratory (hfc)
elink
Publication Type:
Article
Unique ID:
10.1016/j.jchf.2022.03.009
PMID:
35902157
DOI:
10.1016/j.jchf.2022.03.009
Journal:
JACC: Heart Failure
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record
View PubMed Record
View Web of Science Record
View OpenAlex Record

Record Created: